Full efficacy with no CNS side-effects: unachievable panacea or reality?? DMPK considerations in design of drugs with limited brain penetration

Author: Cole Susan   Bagal Sharan   El-Kattan Ayman   Fenner Katherine   Hay Tanya   Kempshall Sarah   Lunn Graham   Varma Manthena   Stupple Paul   Speed William  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.42, Iss.1, 2012-01, pp. : 11-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content